Jiang, Ming <br/><br/>
A phase II prospective study of the "Sandwich" protocol, L-asparaginase, cisplatin, dexamethasone and etoposide chemotherapy combined with concurrent radiation and cisplatin, in newly diagnosed, I/II stage, nasal type, extranodal natural killer/T-cell lymphoma.  [electronic resource] 

 -  Oncotarget  Jul 2017 
 - 50155-50163 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article 
<br/><br/><label>ISSN: </label>1949-2553 
<br/><br/><label>Standard No.: </label>10.18632/oncotarget.16334  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--pharmacology<br/>Asparaginase--pharmacology<br/>Chemoradiotherapy--methods<br/>Cisplatin--pharmacology<br/>Dexamethasone--pharmacology<br/>Etoposide--pharmacology<br/>Female<br/>Humans<br/>Lymphoma, Extranodal NK-T-Cell--drug therapy<br/>Male<br/>Middle Aged<br/>Neoplasm Staging<br/>Prospective Studies<br/>Survival Analysis<br/>Treatment Outcome<br/>Young Adult